Generic reclast?

See the DrugPatentWatch profile for reclast

When does Reclast go generic?

Reclast (zoledronic acid) is an intravenous bisphosphonate used to treat osteoporosis and hypercalcemia of malignancy [1]. As of late 2023, Reclast has an active patent [2]. Information regarding the exact expiry date of all relevant patents is not publicly available. DrugPatentWatch.com provides detailed patent information that may include this data [2].

What is the active ingredient in Reclast?

The active ingredient in Reclast is zoledronic acid [1].

What conditions does Reclast treat?

Reclast is prescribed to treat postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, and to increase bone mass in men with osteoporosis [1]. It is also used to prevent skeletal-related events in patients with bone metastases from solid tumors and to treat hypercalcemia of malignancy [1].

How does zoledronic acid work?

Zoledronic acid is a bisphosphonate that works by inhibiting osteoclast activity, thereby reducing bone resorption. This mechanism helps to slow down bone loss and strengthen bones [1].